Jinyu Bio-Technology Co (SHSE:600201) ROCE %: 6.57% (As of Mar. 2026)


SHSE:600201 Jinyu Bio-Technology Co Ltd SHSE:600201
68 GF Score
Price ¥11.44
GF Value ¥8.19
Valuation Significantly Overvalued
! 5 Warning Signs
View Full Analysis

What is Jinyu Bio-Technology Co ROCE %?

Jinyu Bio-Technology Co SHSE:600201 -5.30% 68 ROCE % is 6.57% as of Mar. 2026. GuruFocus rates SHSE:600201 with a GF Score™ of 68/100 and a GF Value™ of ¥8.19 (Significantly Overvalued). The stock has 5 warning signs investors should review.

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Jinyu Bio-Technology Co's annualized ROCE % for the quarter that ended in Mar. 2026 was 6.57%.

Jinyu Bio-Technology Co  (SHSE:600201) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Jinyu Bio-Technology Co ROCE % Related Terms

Jinyu Bio-Technology Co ROCE % Historical Data

* Premium members only.

The historical data trend for Jinyu Bio-Technology Co's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Jinyu Bio-Technology Co ROCE % Chart

Jinyu Bio-Technology Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
ROCE %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 7.18 4.30 5.37 2.16 1.76

Jinyu Bio-Technology Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
ROCE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 6.39 -1.44 7.07 -5.01 6.57
SHSE:600201
68GF Score
Jinyu Bio-Technology Co Ltd SHSE:600201
ROCE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Jinyu Bio-Technology Co ROCE % Calculation

Jinyu Bio-Technology Co's annualized ROCE % for the fiscal year that ended in Dec. 2025 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Dec. 2025 )  (A: Dec. 2024 )(A: Dec. 2025 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Dec. 2025 )  (A: Dec. 2024 )(A: Dec. 2025 )
=105.09/( ( (6764.669 - 725.058) + (6611.572 - 720.53) )/ 2 )
=105.09/( (6039.611+5891.042)/ 2 )
=105.09/5965.3265
=1.76 %

Jinyu Bio-Technology Co's ROCE % of for the quarter that ended in Mar. 2026 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Mar. 2026 )  (Q: Dec. 2025 )(Q: Mar. 2026 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Mar. 2026 )  (Q: Dec. 2025 )(Q: Mar. 2026 )
=386.936/( ( (6611.572 - 720.53) + (6536.935 - 648.312) )/ 2 )
=386.936/( ( 5891.042 + 5888.623 )/ 2 )
=386.936/5889.8325
=6.57 %

(1) Note: The EBIT data used here is four times the quarterly (Mar. 2026) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about ROCE % →
What does a ROCE % of 6.57% mean?
Jinyu Bio-Technology Co (SHSE:600201) has a ROCE % of 6.57% as of Mar. 2026.
Is Jinyu Bio-Technology Co's ROCE % too high?
Jinyu Bio-Technology Co's current ROCE % is 6.57%. Overall, Jinyu Bio-Technology Co has a GF Score™ of 68/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Jinyu Bio-Technology Co's ROCE % compare to VRTX and REGN?
Jinyu Bio-Technology Co's ROCE % of 6.57% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROCE % for a Biotechnology company?
A good ROCE % depends on the Biotechnology industry context. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROCE % mean?
A high ROCE % can signal that a stock is expensive relative to its fundamentals. Jinyu Bio-Technology Co's current ROCE % is 6.57%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Jinyu Bio-Technology Co stock overvalued right now?
Based on GuruFocus' analysis, Jinyu Bio-Technology Co (SHSE:600201) is currently considered Significantly Overvalued. The stock's GF Value™ is ¥8.19, compared to a current price of ¥11.44 — trading 39.7% above its estimated fair value. The current ROCE % is 6.57%. Jinyu Bio-Technology Co's overall GF Score™ is 68/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROCE % calculated?
ROCE % is calculated from a company's financial statements. For Jinyu Bio-Technology Co (SHSE:600201), the current ROCE % is 6.57% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Jinyu Bio-Technology Co (SHSE:600201) Overvalued in 2026?

Based on GuruFocus' analysis, Jinyu Bio-Technology Co stock appears to be overvalued. The current stock price of ¥11.44 is trading 39.7% above its estimated GF Value™ of ¥8.19. GuruFocus considers Jinyu Bio-Technology Co to be Significantly Overvalued.

Key valuation signals for SHSE:600201:

  • ROCE %: 6.57%
  • GF Value™: ¥8.19 vs. price of ¥11.44 (39.7% above fair value)
  • GF Score™: 68/100 with 5 warning signs

No single metric tells the full story. See the SHSE:600201 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Jinyu Bio-Technology Co Business Description

Address No.1, Jinyu Street, Shaeryu Industrial Park, Economic and Technological Development Zone, Inner Mongolia Autonomous Region, Hohhot, CHN, 010030
Jinyu Bio-Technology Co Ltd is engaged in the development and sales of veterinary biological products. Its products are used for pigs, poultry, pets, and ruminants.
68GF Score

Get the complete analysis for SHSE:600201

ROCE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥11.44
Price
¥8.19
GF Value